Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05737056 |
Other study ID # |
GHRMSA 1278 |
Secondary ID |
2022-A02687-36 |
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
May 9, 2023 |
Est. completion date |
July 28, 2023 |
Study information
Verified date |
October 2023 |
Source |
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The main objective of this study is to describe the management of children with rheumatoid
purpura from admission to the pediatric emergency room to follow-up by primary care
physicians after hospital discharge.
Description:
Secondary objectives The secondary objective is to assess general practitioners current
knowledge and practice of the condition and potential barriers to monitoring and follow-up by
general practitioners.
Conduct of research Children diagnosed with rheumatoid purpura within the past 2 years at the
3 participating sites will be included in the study if parental authority holders do not
object.
Patients will be identified through the Medical Information Department of each hospital.
Parents will be contacted - first by mail, then by phone - to request permission to collect
the child's medical data from medical records, and to retrieve information on the
surveillance and follow-up of the disease by general practitioners up to two years after
diagnosis.